Drugs / CAL
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00060138 | Nov 2002 → Sep 2004 | breast cancer, humoral hypercalcemia of malignancy, metastatic carcinoma in the bone | Chugai Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00060138 ↗ |
| Modality | Monoclonal antibody | “humanized monoclonal antibody to PTHrP” NCT00060138 ↗ |
| Route | Intravenous | “monoclonal antibody CAL IV over 30-60 minutes on day 1” NCT00060138 ↗ |